Pages
Genetics may be the next big thing in medicine, but at what cost?
Dan Gorenstein Apr 12, 2013
Many believe genetics are the next big thing in medicine, but one question for this new era of personalized medicine is cost.
Six diet-related lifestyle changes: Which works for you?
Millie Jefferson Apr 11, 2013
Gluten-free diets are picking up steam, but they're not alone. We pin six more common lifestyle and diet changes.
Biogen Idec CEO on drug costs and taking on multiple sclerosis
Jeremy Hobson Apr 11, 2013
Biogen Idec CEO George Scangos discusses his company's new multiple sclerosis drug, pricing strategy, and research process.
'Chained CPI' hurts seniors
Robert Reich Apr 10, 2013
Obama's proposal to recalculate the rate of inflation hurts seniors who spend more on health care than the rest of us.
Stricter school lunch nutrition standards reduce childhood obesity: Study
David Weinberg Apr 10, 2013
School lunch programs with stricter nutrition standards may be helping to reduce obesity in children, especially those who receive free or reduced lunches.
China tackles a new outbreak of bird flu
Rob Schmitz Apr 5, 2013
Officials in China announced today that a sixth person has died from a new strain of bird flu. 14 people near Shanghai have been infected, and today authorities there decided to close all of the city's poultry markets.
Dementia is highest cost disease and rising
Dan Gorenstein Apr 4, 2013
A report in the latest issue of the New England Journal of Medicine says the U.S. spends more on treating dementia than any other disease including cancer and heart disease.
NIH director welcomes BRAIN initiative
David Brancaccio Apr 4, 2013
National Institutes of Health Director Dr. Francis Collins says government funding is the best way to support large scientific enterprises and fundamental health advances.
Nursing exams keep pace with health care tech advances
Kate Casey Apr 2, 2013
It helps to be up on the latest tech if you want to be a registered nurse. This week the National Council of State Boards of Nursing is rolling out a new update to its nurse licensing exam.
India Novartis patent ruling: Good for access, bad for innovation?
Dan Gorenstein Apr 1, 2013
India's Supreme Court has rejected a patent filed by Swiss drug maker Novartis for its cancer drug. The decision has implications for the pharmaceutical industry and millions of people in poor countries.
